Cefepime vs. Meropenem as Empirical Therapy for Neutropenic Fever in Children with Lymphoma and Solid Tumours

Pediatric Blood and Cancer

Volumn 42, Issue 3, 2004, Pages 284-286

  Kutluk, Tezer ^a   Kurne, Ogün ^a   Akyüz, Canan ^a   Ceyhan, Mehmet ^a   Kanra, Güler ^a   Büyükpamukçu, Münevver ^a   Seçmeer, Gülten ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cefepime; Meropenem; Monotherapy; Neutropenic fever

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CEFEPIME; CEPHALOSPORIN DERIVATIVE; GRANULOCYTE COLONY STIMULATING FACTOR; MEROPENEM; METHOTREXATE; THIENAMYCIN DERIVATIVE;

ADOLESCENT; ADVANCED CANCER; ARTICLE; BACTEREMIA; CANCER COMBINATION CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; EMPIRICISM; FEBRILE NEUTROPENIA; FEMALE; FEVER; HUMAN; INFANT; LYMPHOMA; MALE; MICROBIOLOGY; MONOTHERAPY; NEOPLASM; NEUTROPENIA; NONHODGKIN LYMPHOMA; OUTCOMES RESEARCH; PHARMACOKINETICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SOLID TUMOR; TREATMENT OUTCOME; TURKEY (REPUBLIC);

EID: 1242272104     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.10442     Document Type: Article

References (12)

1. Pizzo PA, Robichaud KJ, Wesley R, et al. Fever in pediatric and young adult patient with cancer. A prospective study of 1001 episodes. Medicine 1982;61:153-165.
2. Petrilli AS, Bianchi A, Kusano E, et al. Fever and granulocytopenia in children with cancer: A study of 299 episodes with two-treatment protocol in Brazil. Med Pediatr Oncol 1993;21:356-361.
3. Pizzo PA, Hathorn JW, Hiemenz J, et al. A randomised trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986;315:552-558.
4. The Meropenem Study Group of Leuven, London and Nijmegen. Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. J Antimicrob Chemother 1995;39: 185-200.
5. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 1996;40:1108-1115.
6. Düzova A, Kutluk T, Kanra G, et al. Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors. Turkish J Pediatr 2001;43:105-109.
7. Kebudi R, Görgǔn O, Ayan İ, et al. Randomised comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumours. Med Pediatr Oncol 2001;36:434-441.
8. Borbolla JR, Lopez-Hernandez MA, Gonzalez-Avante M, et al. Comparison of cefepime versus ceftriaxone-amikacin as empirical regimens for the treatment of febrile neutropenia in acute leukaemia patients. Chemotherapy 2001;47:381-384.
9. Ramphal R, Gücalp R, Rotstein C, et al. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient. Am J Med 1996;100:83S-89S.
10. Yamamura D, Gücalp R, Carlisle P, et al. Open randomised study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients. Antimicrob Agents Chemother 1997;41:1704-1708.
11. Bohme A, Shah PM, Stille W, et al. Piperacillin/tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenic patients: A prospective randomised pilot study. Eur J Med Res 1998;3:324-330.
12. Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-751.